Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring

被引：0
|
作者：
Fuentes-Valenzuela, E. [1 ]
Garcia-Alonso, F. J. [1 ]
Maroto-Martin, C. [1 ]
Juan-Casamayor, L. [1 ]
Garrote Adrados, J. A. [2 ]
Almendros Munoz, R. [3 ]
de Prado, A. [1 ]
Marinero, M. A. [1 ]
Calleja Carbajosa, R. [1 ]
Vara Castrodeza, A. [4 ]
Barrio, J. [1 ]
机构：
[1] Hosp Univ Rio Hortega, Dept Gastroenterol, Valladolid, Spain
[2] Hosp Univ Rio Hortega, Dept Lab Med, Valladolid, Spain
[3] Hosp Univ Rio Hortega, Dept Pharm, Valladolid, Spain
[4] Hosp Univ Rio Hortega, Dept Radiol, Valladolid, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P362
引用
收藏
页码：I369 / I370
页数：2
相关论文
共 50 条
  • [1] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring
    Fuentes-Valenzuela, E.
    Garcia-Alonso, F. J.
    Maroto-Martin, C.
    Juan-Casamayor, L.
    Garrote Adrados, J. A.
    Almendros Munoz, R.
    de Prado, A.
    Marinero, M. A.
    Calleja Carbajosa, R.
    Vara Castrodeza, A.
    Barrio, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
  • [2] Influence of HLADQA1*05 Genotype in Adults With Inflammatory Bowel Disease and Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring: A Retrospective Cohort Study
    Fuentes-Valenzuela, Esteban
    Javier Garcia-Alonso, Francisco
    Maroto-Martin, Carlos
    Juan Casamayor, Laura
    Antonio Garrote, Jose
    Almendros Munoz, Rosendo
    De Prado, Angel
    Vara Castrodeza, Alejando
    Angeles Marinero, Maria
    Calleja Carbajosa, Raquel
    Barrio, Jesus
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (10) : 1586 - 1593
  • [3] HLA-DQA1*05 and development of anti-drug antibodies in anti-TNF treated patients with inflammatory bowel disease
    Lopez-Blanco, Ruben
    Mendez-Lopez, Isabel-Maria
    Recio-Romero, Rafael
    Luque-Fernandez, Rosario
    Caballero-Gonzalez, Abelardo
    Torio-Ruiz, Alberto
    HLA, 2022, 99 (05) : 539 - 540
  • [4] Proactive Therapeutic drug monitoring of Infliximab, but not HLA-DQA1*05, predicts clinical outcome in inflammatory bowel disease
    Alonso, I.
    Carrillo Palau, M.
    Vera, B.
    Vela, M.
    Morant, A.
    Ramos, L.
    Reygosa, C.
    Medina Chico, J. S.
    Barrios, Y.
    Franco, A.
    Gutierrez-Nicolas, F.
    Jimenez, A.
    Hernandez-Guerra, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I597 - I597
  • [5] HLA-DQA1*05 ALLELE CARRAIGE AND ANTI-TNF THERAPY PERSISTENCE IN INFLAMMATORY BOWEL DISEASE
    Doherty, Jayne
    Ryan, Anthony W.
    Quinn, Emma
    Dolan, Jackie
    Corcoran, Roisin
    O'Hara, Fintan
    Bailey, Yvonne
    Mcnamara, Deirdre
    Doherty, Glen
    Kevans, David
    GASTROENTEROLOGY, 2023, 164 (06) : S435 - S436
  • [6] HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease
    Doherty, Jayne
    Ryan, Anthony W.
    Quinn, Emma
    Conroy, Judith
    Dolan, Jackie
    Corcoran, Roisin
    Hara, Fintan O.
    Cullen, Garret
    Sheridan, Juliette
    Bailey, Yvonne
    Dunne, Cara
    Hartery, Karen
    Mcnamara, Deirdre
    Doherty, Glen A.
    Kevans, David
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [7] HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persistence in Inflammatory Bowel Disease
    Doherty, J.
    Ryan, A.
    Quinn, E.
    Dolan, J.
    Corcoran, R.
    Hara, F. O'
    Bailey, Y.
    McNamara, D.
    Doherty, G.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 734 - 734
  • [8] Are We Ready for Proactive Therapeutic Drug Monitoring of Anti-TNF to Optimize Care of Patients With Inflammatory Bowel Disease?
    Charabaty, Aline
    CROHNS & COLITIS 360, 2020, 2 (01)
  • [9] Impact of the HLA DQA1*05 allele on the efficacy of vedolizumab treatment in inflammatory bowel disease
    Torres, S. Castro
    Cuenca, L. Ramiro
    Rodriguez-Moranta, F.
    Rodriguez-Alonso, L.
    Ruiz-Cerulla, A.
    Sanchez-Pastor, E.
    Anton-Guell, S.
    Capon, J. Guardiola
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1031 - I1031
  • [10] HLA DQA1*05 was not associated to primary non-response or loss of response to first anti-TNF in real world Inflammatory Bowel Disease patients.
    Oliver, A. Pascual
    Cuaran, C.
    Casas-Deza, D.
    Garcia-Lopez, S.
    Corsino-Roche, P.
    Sierra Moros, E.
    Julian-Gomara, A. B.
    Vicente-Lidon, R.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 756 - 757
12345